PT - JOURNAL ARTICLE AU - Salvatore, Maxwell AU - Gu, Tian AU - Mack, Jasmine A. AU - Sankar, Swaraaj Prabhu AU - Patil, Snehal AU - Valley, Thomas S. AU - Singh, Karandeep AU - Nallamothu, Brahmajee K. AU - Kheterpal, Sachin AU - Lisabeth, Lynda AU - Fritsche, Lars G. AU - Mukherjee, Bhramar TI - A phenome-wide association study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in Michigan Medicine AID - 10.1101/2020.06.29.20141564 DP - 2021 Jan 01 TA - medRxiv PG - 2020.06.29.20141564 4099 - http://medrxiv.org/content/early/2021/02/20/2020.06.29.20141564.short 4100 - http://medrxiv.org/content/early/2021/02/20/2020.06.29.20141564.full AB - Background We perform a phenome-wide scan to identify pre-existing conditions related to COVID-19 susceptibility and prognosis across the medical phenome and how they vary by race.Methods The study is comprised of 53,853 patients who were tested/positive for COVID-19 between March 10 and September 2, 2020 at a large academic medical center.Results Pre-existing conditions strongly associated with hospitalization were renal failure, pulmonary heart disease, and respiratory failure. Hematopoietic conditions were associated with ICU admission/mortality and mental disorders were associated with mortality in non-Hispanic Whites. Circulatory system and genitourinary conditions were associated with ICU admission/mortality in non-Hispanic Blacks.Conclusions Understanding pre-existing clinical diagnoses related to COVID-19 outcomes informs the need for targeted screening to support specific vulnerable populations to improve disease prevention and healthcare delivery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the University of Michigan Precision Health Initiative, University of Michigan Rogel Cancer Center, Michigan Institute of Data Science, NSF DMS 1712933 and NIH NCI P30 CA 046592-30-S3.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study protocols were reviewed and approved by the University of Michigan Medical School Institutional Review Board (IRB ID HUM00180294).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be shared publicly due to patient confidentiality. The data underlying the results presented in the study are available from University of Michigan Data Office for Clinical & Translational Research for researchers who meet the criteria for access to confidential data.Blacknon-Hispanic Black/African AmericanEHRelectronic health recordICDInternational Classification of DiseaseICUintensive care unitMMMichigan MedicineNaNDANational Neighborhood Data ArchiveORodds ratioPheWASphenome-wide association studySESsocioeconomic statusWhitenon-Hispanic White